We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Join us at the 2nd Allogeneic Cell Therapies Summit Europe 2023 in London, UK.
Presentation Details
Topic: Risk mitigation strategies for critical raw materials in cell therapy manufacturing: addressing cryopreservation.
- Keeping an ATMP manufacturing workflow in a state of control entails risk assessing critical raw materials
- Cryopreservation is key to address multiple challenges in cell therapy manufacturing
- DMSO is commonly used as a cryoprotectant, but has risks that can be adressed by DMSO-free formulations
Presenter: Gonçalo Regalo, PhD, Strategic Business Development, Life Sciences, FUJIFILM Irvine Scientific
Allogeneic Cell Therapies Summit Europe 2023
Jan 30, 2023
- Feb 1, 2023
